|
Outcomes
|
All-cause mortality
|
All-cause mortality
|
All-cause mortality
|
|---|
|
BMI
|
BF
|
LMI
|
|---|
|
Tertile 1
|
Tertile 2
|
Tertile 3
|
Tertile 1
|
Tertile 2
|
Tertile 3
|
Tertile 1
|
Tertile 2
|
Tertile 3
|
|---|
|
No. of patients
|
n = 1003
|
n = 993
|
n = 993
|
n = 996
|
n = 997
|
n = 996
|
n = 997
|
n = 996
|
n = 996
|
|
Total CAD patients (n = 2989), HR (95 % CI)
|
|
No. of deaths
|
116
|
78
|
77
|
80
|
89
|
102
|
124
|
87
|
60
|
|
Unadjusted
|
2.91 (1.99–4.26)
|
2.30 (1.42–3.75)
|
4.03 (2.57–6.34)
|
2.75 (1.64–4.61)
|
3.15 (2.05–4.86)
|
2.97 (2.01–4.40)
|
2.10 (1.46–3.03)
|
3.32 (2.15–5.12)
|
3.93 (2.28–6.78)
|
|
Adjusteda
|
1.98 (1.28–3.08)
|
1.12 (0.65–1.94)
|
2.08 (1.22–3.55)
|
1.64(0.92–2.93)
|
1.57(0.95–2.60)
|
1.95(1.25–3.05)
|
1.82 (1.19–2.79)
|
1.69 (1.01–2.82)
|
1.71 (0.91–3.20)
|
|
ACS patients (n = 2163), HR (95 % CI)
|
|
No. of deaths
|
89
|
63
|
63
|
57
|
69
|
89
|
100
|
67
|
48
|
|
Unadjusted
|
3.11 (2.03–4.80)
|
2.54 (1.50–4.29)
|
4.24 (2.58–6.98)
|
2.42 (1.30–4.49)
|
3.64 (2.24–5.90)
|
3.16 (2.08–4.79)
|
2.35 (1.57–3.50)
|
3.22 (1.96–5.29)
|
4.37 (2.42–7.90)
|
|
Adjusteda
|
1.67 (1.01–2.76)
|
1.02 (0.56–1.87)
|
1.97 (1.07–3.64)
|
1.11 (0.55–2.26)
|
1.39 (0.76–2.54)
|
1.93 (1.20–3.11)
|
1.74 (1.10–2.77)
|
1.14 (0.62–2.12)
|
1.84 (0.91–3.69)
|
- Renal function was estimated by levels of the creatinine clearance and binary classified by ≥60 and <60 min/ml
-
BMI body mass index; BF body fat; LMI lean mass index; HR hazard ratio; CI confidence interval; CAD coronary artery disease; ACS acute coronary syndrome; ACE angiotensin-converting enzyme; ARBs angiotensin-receptor blockers
-
aRisk factors adjustment included age, sex, medical history (pre-hypertension and pre-diabetes mellitus), heart function (Killip level), severity of CAD (left main artery and three vessel diseases), discharge medication (statin, ACE inhibitors or ARBs and beta-receptor blockers)
